Detection of the Hepatitis B Virus X Protein (HBx) Antigen and Anti-HBx Antibodies in Cases of Human Hepatocellular Carcinoma

Journal of Clinical Microbiology

Volumn 41, Issue 12, 2003, Pages 5598-5603

  Hwang, Guang Yuh ^a   Lin, Chuang Yu ^a   Huang, Li Mei ^a   Wang, Yan Hsiung ^a   Wang, Jing Chyi ^a   Hsu, Ching Ting ^a   Yang, Sheng Shun ^b   Wu, Cheng Chung ^b  

^a TUNGHAI UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; HEPATITIS B ANTIBODY; HEPATITIS B VIRUS X PROTEIN; HEPATITIS BX ANTIBODY; HYBRID PROTEIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; MOLECULAR SIZE; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROGNOSIS; RECOMBINANT DNA TECHNOLOGY; WESTERN BLOTTING;

ADULT; AGED; ANTIBODIES, VIRAL; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CLONING, MOLECULAR; DNA, VIRAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLASMIDS; RECOMBINANT PROTEINS; TRANS-ACTIVATORS;

DNA VIRUSES; ESCHERICHIA COLI; HEPATITIS B VIRUS;

EID: 0347479386     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.12.5598-5603.2003     Document Type: Article

References (44)

1. Beasley, R. P. 1988. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
2. Cartwright, G. A., J. S. Rothel, and M. W. Lightowlers. 1995. Conventional immunoassays underestimate anti-GST antibody titre. J. Immunol. Methods 179:31-35.
3. Chen, H. S., S. Kaneko, R. Girones, R. W. Anderson, W. E. Hornbuckle, B. C. Tennant, P. J. Cote, J. L. Gerin, R. H. Purcell, and R. H. Miller. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J. Virol. 67:1218-1226.
4. Diamantis, I, D., C. E. MeGandy, T. J. Chen, Y. F. Liaw, F. Gudat, and L. Bianchi. 1992 Hepatitis B X gene expression in hepatocellular carcinoma. J. Hepatol. 15:400-403.
5. Elfassi, E., W. A. Haseltine, and J. L. Dienstag. 1986. Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector. Proc. Natl. Acad. Sci. USA 83:2219-2222.
6. Feitelson, M. A., and M. M. Clayton. 1990. X antigen polypeptides in the sera of hepatitis B virus-infected patients. Virology 177:367-371.
7. Feitelson, M. A., M. M. Clayton, and B. S. Blumberg. 1990. X antigen/antibody markers in hepadnavirus infections. Gastroenterology 98:1071-1078.
8. Feitelson, M. A., and L. X. Duan. 1997. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am. J. Pathol. 150:1141-1157.
9. Frangioni, J. V., and B. G. Neel. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion protein. Anal. Biochem. 210:179-187.
10. Galibert, F., E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
11. Hess, J., M. Stemler, H. Will, C. H. Schröder, J. Kühn, and R. Braun. 1988. Frequent detection of antibodies to hepatitis B virus X-protein in acute, chronic and resolved infection. Med. Microbiol. Immunol. 177:195-205.
12. Hollinger, F. B. 1990. Hepatitis B virus, p. 2171-2236. In B. N. Fields (ed.), Virology. Raven Press, Ltd., New York, N.Y.
13. Hwang, G. Y., J. C. Wang, and C. C. Wu. 1999. Immunological characterization of two major secreted forms of recombinant hepatitis B virus e antigen. Virus Res. 59:203-210.
14. Kay, A., E. Mandart, C. Trepo, and F. Galibert. 1985. The HBV HBx gene expressed in E. coli is recognized by sera from hepatitis patients. EMBO J. 4:1287-1292.
15. Kekule, A. S., U. Lauer, L. Weiss, B. Luber, and P. H. Hofschneider. 1993. Hepatitis B virus transactivator Hbx uses a tumor promoter signalling pathway. Nature 361:742-745.
16. Kim, C. M., K. Koike, I. Salto, T. Miyamura, and J. Gilbert. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (London) 351:317-320.
17. Koike, K., K. Moriya, S. Iino, H. Yotsuyanagi, Y. Endo, T. Miyamura, and K. Kurokawa. 1994. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810819.
18. Koike, K., K. Moriya, H. Yotsuyanagi, S. Iino, and K. Kurokawa. 1994, Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Investig. 94:44-49.
19. Koike, K. 1999. Transgenic mouse models of viral hepatitis: insight into viral hepatocarcinogenesis. Viral Hepatitis 5:177-203.
20. Kumar, V., N. Jayasuryan, H. Reddi, D. Sahal, and S. K. Panada. 1998. A monoclonal antibody against the X protein of hepatitis B virus: fine mapping of its epitope and application in a quantitative ELISA of the X protein in sera of hepatitis B patients. Hybridoma 17:157-164.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Levrero, M., M. Stemler, C. Pasquinelli, A. Alberti, O. Jean-Jean, A. Franco, C. Balsano, D. Diop, C. Brechot, M. Melegari, E. Villa, V. Barnaba, M. Perricaudet, and H. Will. 1991. Significance of anti-HBx antibodies in hepatitis B virus infection. Hepatologv 13:143-149.
23. Levrero, M., O. Jean-Jean, C. Balsano, H. Will, and M. Perricaudet. 1990. Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection. Virology 174:299-304.
24. Meyers, M. L., L. V. Trepo, N. Nath, and J. J. Sninsky. 1986. Hepatitis B virus polypeptide X: expression in Escherichia coli and identification of specific antibodies in sera from hepatitis B virus-infected humans. J. Virol. 57:101-109.
25. Milich, D. R., J. E. Jones, J. L. Hughes, J. Price, A. K. Raney, and A. McLanchlan. 1990. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA 87:6599-6603.
26. Miller, R. H., and W. S. Robinson. 1986. Common evolutionary origin of hepatitis B virus and retroviruses. Proc. Natl. Acad. Sci. USA 83:2531-2535.
27. Moriarty, A. M., H. Alexander, R. A. Lerner, and G. B. Thornton. 1985. Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 227:429-433.
28. Nakatake, H., O. Chisaka, S. Yamamoto, K. Matsubara, and R. Koshy. 1993. Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication. Virology 195:305-314.
29. Park, O. Y., Y. H. Jin, M. Lee, H. J. Shin, H. I. Kim, H. Cho, C. W. Yun, J. K. Youn, and S. Park. 2000. Characterization and gene cloning of monoclonal antibody specific for the hepatitis B virus X protein. Hybridoma 19:73-80.
30. Rossner, M. T. 1992. Hepatitis B virus X gene product: a promiscuous transcriptional activator. J. Med. Virol. 36:101-117.
31. Seto, E., P. J. Mitchell, and T. S. Yen. 1989. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (London) 344:72-74.
32. Shirakata, Y., M. Kawada, Y. Fujiki, H. Sano, M. Oda, K. Yaginuma, M. Kobayashi, and K. Koike. 1989. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn. J. Cancer Res. 80:617-621.
33. Spandau, D. F., and C. H. Lee. 1988. trans-activation of viral enhancers by the hepatitis B virus X protein. J. Virol. 62:427-434.
34. Steel, R. G. D., J. H. Torrie, and D. A. Dickey. 1997. Principles and procedures of statistics, 3rd ed. McGraw-Hill, Inc., New York, N.Y.
35. Twu, J. S., K. Chu, and W. S. Robinson. 1989. Hepatitis B virus X gene activates KB-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 86:5168-5172.
36. Vitvitski-Trépo, L., A. Kay, C. Pichoud, P. Chevallier, S. de Dinechin, B.-M. Shamoon, E. Mandart, C. Trépo, and F. Galibert. 1990. Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection. Hepatology 12:1278-1283.
37. Wang, W., W. T. London, L. Lega, and M. A. Feitelson. 1991. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis. Hepatology 14:29-37.
38. Yeh, C. T. 2000. Hepatitis B virus X protein: searching for a role in hepatocarcinogenesis. J. Gastroenterol. Hepatol. 15:339-341.
39. Yen, T. S. B. 1996. Hepadnaviral X protein: review of recent progress. J. Biomed. Sci. 3:20-30.
40. Zahm, P., P. H. Hofschneider, and R. Koshy. 1988. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3:169-177.
41. Zentgraf, H., G. Herrmann, R. Klein, P. Schranz, I. Loncarevic, D. Herrmann, K. Hubner, and C. H. Schroder. 1990. Mouse monoclonal antibody directed against hepatitis B virus X protein synthesized in Escherichia coli: detection of reactive antigen in liver cell carcinoma and chronic hepatitis. Oncology 47:143-148.
42. Zhu, M., W. T. London, L. X. Duan, and M. A. Feitelson. 1993. The value of hepatitis B X antigen as a prognostic marker in the development of hepatocellular carcinoma. Int. J. Cancer 55:571-576.
43. Zinkernagel, R. M., and P. C. Doherty. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lympholytic choriomeningitis within a syngeneicof semiallogeneic system. Nature 248:701-702.
44. Zoulim, F., J. Saputelli, and C. Seeger. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68:2026-2030.